Childhood retinal dystrophies are highly heterogeneous

Article

A paper in the British Journal of Ophthalmology states that childhood retinal dystrophies are highly heterogeneous.

A paper in the British Journal of Ophthalmology states that childhood retinal dystrophies are highly heterogeneous.

The prospective, population-based, cross-sectional study, compiled by Professor Jugnoo S. Rahi et al., MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, UK, included 241 patients with 24 different diagnoses.

All patients were aged

There was a higher rate of hereditary retinal disorders seen in males, compared to females and in Asian children compared to white children. Additional systemic disorders were found in 14% of children and 13% had dual sensory impairment.

Annual incidence of retinal disorders was 1.4/100,000 children aged between 0 and 15 years, and 22.3/100,000 children by the age of 16 years.

The study provides useful information on disease incidence, distributions and management. The results are significant to the development of future treatments and novel therapies.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.